TP53 and non-small cell lung carcinoma: Similar with the results of cellular studies, Lai et al. found that the expression of p53 had nothing to do with pathological staging and had no correlation with the prognosis of NSCLC by investigating 114 NSCLC cases with different clinical stages [51].